Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Journal of Biomolecular Screening|October 12, 2004
A generally applicable, high-throughput screening-compatible assay to identify, evaluate, and optimize antimicrobial agents for drug therapyGerald Kleymann, Hans-Otto WerlingHerpes : the Journal of the IHMF|October 28, 2003
New antiviral drugs that target herpesvirus helicase primase enzymesGerald KleymannExpert Opinion on Investigational Drugs|January 31, 2003
Novel agents and strategies to treat herpes simplex virus infectionsGerald KleymannExpert Opinion on Investigational Drugs|March 11, 2005
Agents and strategies in development for improved management of herpes simplex virus infection and diseaseGerald KleymannAntiviral Chemistry & Chemotherapy|July 23, 2004
Helicase primase: targeting the Achilles heel of herpes simplex virusesGerald KleymannExpert Opinion on Therapeutic Patents|August 15, 2022
Helicase-primase inhibitors from Medshine Discovery Inc. (WO2018/127207 and WO2020/007355) for the treatment of herpes simplex virus infections - structure proposal for Phaeno Therapeutics drug candidate HN0037Christian Gege, Gerald KleymannBioorganic & Medicinal Chemistry Letters|April 20, 2024
Replacement of sulfonamide by sulfoximine within a helicase-primase inhibitor with restricted flexibilityChristian Gege, Gerald KleymannExpert Opinion on Therapeutic Patents|July 27, 2026
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure-activity relationships and patent coverageChristian Gege, Gerald KleymannExpert Opinion on Therapeutic Patents|August 19, 2025
Evaluation of the patent portfolio for helicase-primase inhibitor ABI-5366 of Assembly biosciences incChristian Gege, Gerald KleymannExpert Opinion on Therapeutic Patents|September 12, 2024
Helicase-primase inhibitors for the treatment of herpes simplex virus infections - patent evaluation of WO2023/225162 from Gilead Sciences IncChristian Gege, Gerald KleymannPageof 4